Login or Sign Up
Kobo Biotech Ltd. Financials
16:01 Jul 18
Kobo Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Kobo Biotech Ltd.
Industry Pharmaceuticals
16:01 Jul 18
Quality
0/100
Not Eligible
Valuation
7/100
Expensive Valuation
Technical
36/100
Technically Neutral
Strength
5
Weakness
7
Opportunity
0
Threats
0
-65.59 %
ROE %
-8.80 %
ROA %
0.00
EPS
23.59
BVPS
-33.73 %
Net Profit Margin
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | ||
|---|---|---|---|---|---|
| Net Sales | 162.12 | 287.26 | 403.66 | 103.19 | |
| Operating Expenses + | 132.93 | 238.39 | 360.77 | 104.11 | |
| Raw Material | 106.39 | 199.4 | 347.98 | 96.87 | |
| Increase Decrease in Cost | -5.93 | 6.7 | -9.14 | -4.51 | |
| Other Manufacturing Expense | 18.75 | 14.8 | 6.73 | 3.9 | |
| Employee Cost | 10.32 | 13.05 | 12.25 | 9.03 | |
| Miscellaneous Expenses | 3.4 | 4.44 | 2.95 | -1.18 | |
| Operating Profit | 29.19 | 48.87 | 42.89 | -0.92 | |
| Other Income | 0.25 | 0.23 | 0.37 | 0.25 | |
| Depreciation | 6.12 | 10.86 | 9.97 | 9.62 | |
| Interest | 13.48 | 20.58 | 18.41 | 23.98 | |
| Profit before tax and exceptio.. | 9.84 | 17.67 | 14.87 | -34.27 | |
| Exceptional Items | 0 | 0 | 0 | 0 | |
| PBT | 9.84 | 17.67 | 14.87 | -34.27 | |
| Provision for Taxation | 0 | 2 | 1.21 | 0.54 | |
| Net Profit | 9.84 | 15.67 | 13.67 | -34.82 | |
| NET Profit after MI | 9.84 | 15.12 | 13.99 | -34.82 | |
| EPS | 4.38 | 4.47 | 6.22 | -15.47 | |
| Operating Profit Margin (%) | 18.01 | 17.01 | 10.63 | -0.89 | |
| Net Profit Margin (%) | 6.07 | 5.26 | 3.47 | -33.74 |
Kobo Biotech Ltd. Shareholding
Promoter
FII
Public
Mutual Funds
Other Institutions
All Data in Percentage (%)
| Mar 24 | |
|---|---|
| Promoter | 45.00 |
| FII | 0.00 |
| MF | 0.00 |
| Others | 0.60 |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
Back
OTP sent to your mobile number/email. Please enter it below to verify.
